Celebrating Innovation in Patient Experience: 2026 Patient Innovators Awards Announced
Celebrating Innovation in Patient Experience: 2026 Patient Innovators Awards Announced
On October 6, 2026, the much-anticipated Patient Innovators Awards took place at Courier Health's third annual summit in New York City, recognizing exceptional contributions to the improvement of patient experiences by various biopharma teams. The event gathered over 75 biopharma companies, uniting leaders from Patient Services, Access Reimbursement, and Commercial IT Analytics to celebrate innovation and excellence in patient care delivery.
This year's awards were particularly special, as they showcased teams and individuals who are significantly changing patient access and outcomes in an industry that continually seeks ways to improve the patient journey. Key winners included:
- - Rare Disease Champions of the Year: KalVista, a Company of Chiesi Group
- - Patient Services Team of the Year: Priovant Therapeutics
- - Field Access Team of the Year: UCB, Inc.
- - Patient Champion of the Year: Rob Chuba, Alkermes
- - Patient Innovators of the Year: Bristol Myers Squibb's CAR T-cell therapy Patient Access Support Services (PASS) team
In his opening keynote speech, Danny Sigurdson, Founder and CEO of Courier Health, emphasized the transformative moment we find ourselves in, stating that organizations must take greater internal control over their programs. He emphasized that ownership of data, outcome measurements, and the integration of AI-enabled workflows are pivotal for future success.
With these insights, he urged attendees to recognize that a strong foundation in operational practices would empower them to focus on what truly matters: supporting patients and healthcare providers.
Lee Liberator, Vice President of Patient Services and Reimbursement at Priovant Therapeutics, expressed gratitude for being named the Patient Services Team of the Year, highlighting their unique program tailored to address the specific needs of patients. “We are honored to be acknowledged for our commitment to innovation and enhancing the patient experience,” he remarked, reflecting the collective sentiments of the awardees who showed a steadfast commitment to put patients first.
The summit showcased a stellar lineup of expert speakers from major companies, including Alkermes, Genentech, and others, delivering insights and narratives that highlighted the importance of collaboration and innovation in driving patient-centric solutions in the pharmacological landscape.
One particularly moving moment was a personal story shared by Mark Dant, a rare disease advocate and Volunteer Executive Director for the Ryan Foundation, capturing the audience's attention and further emphasizing the importance of listening to patient voices in the industry.
As Courier Health continues its mission to improve the experience of hundreds of millions living with chronic or rare conditions, the recognition of such dedicated teams serves as a beacon of hope and progress. With a focus on enhancing patient starts, minimizing time-to-start, and ensuring ongoing adherence to life-altering therapies, Courier is paving the way for continued advancements in patient experience solutions within the life sciences sector.
For more information on this year’s winners and to explore the contributions made toward the industry’s future, please visit Courier Health.
With the announcement of these awards, Courier Health and its partners have made clear that the journey toward improving patient care is collaborative, innovative, and, most importantly, driven by a commitment to placing patients at the center of healthcare solutions.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.